483
ExcelvisionExcelvision – FDA 483, Jul 7, 2023
Record Details
An FDA inspection of Excelvision, a drug manufacturer in Annonay, France, from June 29 to July 7, 2023, revealed significant deficiencies in aseptic processing. The firm's investigations into unexplained discrepancies and mold contamination were inadequate, and its cleaning, disinfection, and environmental monitoring systems were found to be deficient. These issues indicate a high risk of microbiological contamination for sterile drug products.
View Company Profile
ID · ce597575-4f9b-4672-b921-3039a5eb2c51
Other documents for Excelvision
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.